BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17396140)

  • 1. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder.
    Sukov WR; Cheville JC; Carlson AW; Shearer BM; Piatigorsky EJ; Grogg KL; Sebo TJ; Sinnwell JP; Ketterling RP
    Mod Pathol; 2007 May; 20(5):592-603. PubMed ID: 17396140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.
    Tsuzuki T; Magi-Galluzzi C; Epstein JI
    Am J Surg Pathol; 2004 Dec; 28(12):1609-14. PubMed ID: 15577680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining.
    Rao RN; Ranjan P; Singla N; Pandey R
    Urol Ann; 2012 May; 4(2):115-8. PubMed ID: 22629012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.
    Choi E; Williamson SR; Montironi R; Zhang S; Wang M; Eble JN; Grignon DJ; Lopez-Beltran A; Idrees MT; Baldridge LA; Scarpelli M; Jones CL; Wang L; MacLennan GT; Osunkoya AO; Cheng L
    Histopathology; 2015 Jul; 67(1):20-38. PubMed ID: 25406945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
    Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA
    Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.
    Hornick JL; Sholl LM; Dal Cin P; Childress MA; Lovly CM
    Mod Pathol; 2015 May; 28(5):732-9. PubMed ID: 25612511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder.
    Bertz S; Stöhr R; Gaisa NT; Wullich B; Hartmann A; Agaimy A
    Histopathology; 2020 Dec; 77(6):949-962. PubMed ID: 32645760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
    Acosta AM; Demicco EG; Dal Cin P; Hirsch MS; Fletcher CDM; Jo VY
    Mod Pathol; 2021 Feb; 34(2):469-477. PubMed ID: 32908253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report.
    Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC
    Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall.
    Kataoka TR; Yamashita N; Furuhata A; Hirata M; Ishida T; Nakamura I; Hirota S; Haga H; Katsuyama E
    World J Surg Oncol; 2014 Jun; 12():186. PubMed ID: 24938355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature.
    Freeman A; Geddes N; Munson P; Joseph J; Ramani P; Sandison A; Fisher C; Parkinson MC
    Mod Pathol; 2004 Jul; 17(7):765-71. PubMed ID: 15105807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract.
    Hirsch MS; Dal Cin P; Fletcher CD
    Histopathology; 2006 Apr; 48(5):569-78. PubMed ID: 16623783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
    Yu L; Liu J; Lao IW; Luo Z; Wang J
    Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.
    Inamura K; Kobayashi M; Nagano H; Sugiura Y; Ogawa M; Masuda H; Yonese J; Ishikawa Y
    Hum Pathol; 2017 Nov; 69():96-100. PubMed ID: 28504207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
    Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of pan-Trk immunohistochemistry for inflammatory myofibroblastic tumours.
    Yamamoto H; Nozaki Y; Kohashi K; Kinoshita I; Oda Y
    Histopathology; 2020 Apr; 76(5):774-778. PubMed ID: 31578734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation.
    Antonescu CR; Sung YS; Zhang L; Agaram NP; Fletcher CD
    Am J Surg Pathol; 2017 May; 41(5):677-684. PubMed ID: 28248815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK Expression in Angiomatoid Fibrous Histiocytoma: A Potential Diagnostic Pitfall.
    Cheah AL; Zou Y; Lanigan C; Billings SD; Rubin BP; Hornick JL; Goldblum JR
    Am J Surg Pathol; 2019 Jan; 43(1):93-101. PubMed ID: 29877921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
    Qiu X; Montgomery E; Sun B
    Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.